Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus

Table 2

Length (in years) of patients on PPI therapy and their matched controls. The control group was matched to those on PPI treatment with similar HbA1c data points. The percentages shown in the table demonstrate a similar distribution between both groups.

	PPI ()	Control ()
Years on PPI
One	908 (37.5%)	3047 (43%)
Two	544 (22.5%)	1550 (21.9%)
Three	421 (17.4%)	1144 (16.1%)
Four	255 (10.5%)	614 (8.7%)
Five	180 (7.4%)	344 (4.9%)
Six	111 (4.6%)	386 (5.4%)